Product NDC: | 52959-225 |
Proprietary Name: | Meclizine Hydrochloride |
Non Proprietary Name: | meclizine hydrochloride |
Active Ingredient(s): | 12.5 mg/1 & nbsp; meclizine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52959-225 |
Labeler Name: | H.J. Harkins Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087127 |
Marketing Category: | ANDA |
Start Marketing Date: | 19810603 |
Package NDC: | 52959-225-00 |
Package Description: | 100 TABLET in 1 BOTTLE (52959-225-00) |
NDC Code | 52959-225-00 |
Proprietary Name | Meclizine Hydrochloride |
Package Description | 100 TABLET in 1 BOTTLE (52959-225-00) |
Product NDC | 52959-225 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | meclizine hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19810603 |
Marketing Category Name | ANDA |
Labeler Name | H.J. Harkins Company, Inc. |
Substance Name | MECLIZINE HYDROCHLORIDE |
Strength Number | 12.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antiemetic [EPC],Emesis Suppression [PE] |